|
MYL's Operating Income Growth by Quarter and Year
Mylan N V 's Operating Income results by quarter and year
|
Select the Comparisons :
|
|
Select the Ratio:
|
Operating Income Growth Y/Y▼
|
Operating Income Growth Y/Y▼
|
| MYL Operating Income (in millions $) |
FY 2020 |
FY 2019 |
FY 2018 |
FY 2017 |
| IV Quarter |
December |
-
|
391.80
|
232.80
|
1,024.60
|
| III Quarter |
September |
351.40
|
323.70
|
338.20
|
316.00
|
| II Quarter |
June |
134.20
|
-
|
178.90
|
227.20
|
| I Quarter |
March |
184.70
|
-
|
155.70
|
315.80
|
| FY |
|
670.30
|
715.50
|
905.60
|
1,883.60
|
| MYL Operating Income third quarter 2020 Y/Y Growth Comment |
Mylan N v achieved in the third quarter 2020, above Company average Operating Income improvement of 8.56% year on year, to $ 351.40 millions.
Looking into third quarter 2020 results within Major Pharmaceutical Preparations industry 24 other companies have achieved higher Operating Income growth. While Mylan N V ' s Operating Income increase of 8.56% ranks overall at the positon no. 1074 in the third quarter 2020.
Explain Operating Income growth
|
| MYL Operating Income ( Y/Y Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
- |
68.3 % |
-77.28 % |
- |
| III Quarter |
September |
8.56 % |
-4.29 % |
7.03 % |
-23.1 % |
| II Quarter |
June |
- |
- |
-21.26 % |
115.15 % |
| I Quarter |
March |
- |
- |
-50.7 % |
-25.5 % |
| FY |
|
- |
-20.99 % |
-51.92 % |
132.63 % |
MYL Operating Income (Quarter on Quarter Growth %) |
2020
|
2019 |
2018 |
2017 |
| IV Quarter |
December |
- |
21.04 % |
-31.16 % |
224.24 % |
| III Quarter |
September |
161.85 % |
- |
89.04 % |
39.08 % |
| II Quarter |
June |
-27.34 % |
- |
14.9 % |
-28.06 % |
| I Quarter |
March |
-52.86 % |
- |
-84.8 % |
- |
| FY (Year on Year) |
|
- |
-20.99 % |
-51.92 % |
132.63 % |
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 201.04 % |
8.45 % |
-50.08 % |
| (March 31 2009) |
|
(Sep. 30, 2009) |
|
|
| Operating Income Y/Y Growth Statistics |
| High |
Average |
Low |
| 201.04 % |
8.45 % |
-50.08 % |
| (March 31 2009) |
|
(Sep. 30, 2009) |
|
| Operating Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020 |
Mylan N V 's Q/Q Operating Income Growth
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 657.88 % |
35.76 % |
-100 % |
| (Sep. 30, 2008) |
|
(Mar 31 2019) |
| MYL's III. Quarter Q/Q Operating Income Comment |
Mylan N v achieved in the III. Quarter 2020 above company average sequential Operating Income doubling of 161.85%, to $ 351.40 millions, from $134.20 millions in the second quarter.
Mylan N V is impressively improving, not only recording higher then regular growth, but also improving speed.
Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Mylan N V 's Operating Income growth quarter on quarter, overall rank is 270. |
|
|
|
| Operating Income Q/Q Growth Statistics |
| High |
Average |
Low |
| 657.88 % |
35.76 % |
-100 % |
| (Sep. 30, 2008) |
|
(Mar 31 2019) |
| MYL's III. Quarter Q/Q Operating Income Comment |
Mylan N v achieved in the III. Quarter 2020 above company average sequential Operating Income doubling of 161.85%, to $ 351.40 millions, from $134.20 millions in the second quarter.
Major Pharmaceutical Preparations company is impressively improving, with reporting better then normal increase, and additionally accelerating pace, Archie Wood, an industry consultant said.
Within Major Pharmaceutical Preparations industry 3 other companies have achieved higher Operating Income quarter on quarter growth. While Mylan N V 's Operating Income growth quarter on quarter, overall rank is 270. |
|
Mylan N V 's 12 Months Operating Income Growth Year on Year
Operating Income TTM Growth |
12 Months Ending
(Sep 30 2020) |
12 Months Ending
(Jun 30 2020) |
12 Months Ending
(Mar 31 2020) |
12 Months Ending
(Dec 31 2019) |
12 Months Ending
(Sep 30 2019) |
| Cumulative Operating Income 12 Months Ending |
$ 1,062.10 |
$ 1,034.40 |
$ 0.00 |
$ 0.00 |
$ 0.00 |
| Y / Y Operating Income Growth (TTM) |
- |
- |
- |
- |
- |
| Year on Year Operating Income Growth Overall
Ranking |
# |
# |
# |
# |
# |
| Seqeuential Operating Income Change (TTM) |
2.68 % |
- |
- |
- |
- |
| Seq. Operating Income Growth (TTM) Overall
Ranking |
# 1075 |
# 1075 |
# 0 |
# 0 |
# 0 |
| Cumulative Operating Income growth
Comment |
Although Mylan N V 's Annual Operating Income growth year on year were below company's average 22.43% , Operating Income announced in the Sep 30 2020 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 8.56% year on year, from % in Jun 30 2020. And, Mylan N V had the highest Operating Income growth, in Major Pharmaceutical Preparations industry.
Mylan N v achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
201.04 % |
8.45 % |
-50.08 % |
|
|
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
145.65 % |
22.43 % |
-52.75 % |
| (Mar 31 2018) |
|
(Mar 31 2019) |
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 25 |
| Sector |
# 107 |
| S&P 500 |
# 1075 |
|
| Cumulative Operating Income growth
Comment |
Although Mylan N V 's Annual Operating Income growth year on year were below company's average 22.43% , Operating Income announced in the Sep 30 2020 period, show improvement in Operating Income trend, to cumulative trailing twelve month growth of 8.56% year on year, from % in Jun 30 2020. And, Mylan N V had the highest Operating Income growth, in Major Pharmaceutical Preparations industry.
Mylan N v achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. . |
| Operating Income TTM Q/Q Growth Statistics |
| High |
Average |
Low |
201.04 % |
8.45 % |
-50.08 % |
|
|
|
| Operating Income TTM Y/Y Growth Statistics |
| High |
Average |
Low |
145.65 % |
22.43 % |
-52.75 % |
| (Mar 31 2018) |
|
(Mar 31 2019) |
| Operating Income TTM Q/Q Growth Company Ranking |
| Within: |
No. |
| Industry |
# 25 |
| Sector |
# 107 |
| S&P 500 |
# 1075 |
|
14.45%